Of those with chronic pain in a recent study, 34.6 percent had anxiety diagnoses and 12.2 percent had depression diagnoses
MONDAY, Sept. 16, 2024 (HealthDay News) — Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their peers without chronic pain, according to a study published online Sept. 9 in JAMA Pediatrics.
Joanne Dudeney, Ph.D., from Macquarie University in Sydney, and colleagues reported the prevalence of clinical anxiety and depression for youth with chronic pain and compared symptoms of anxiety and depression between youth with and without chronic pain. Data were obtained from 79 studies, with 22,956 youth (12,614 with chronic pain).
The researchers found that the prevalence estimate of anxiety diagnoses was 34.6 percent, and 23.9 percent exceeded clinical cutoff scores. The prevalence of depression diagnoses was 12.2 percent; 23.5 percent exceeded clinical cutoff scores. Compared with controls, youth with chronic pain had greater symptoms of anxiety and depression (g = 0.61 and 0.74, respectively). Anxiety and depression may be moderated by sex, age, pain location, and recruitment sample. For all outcomes, there was considerable heterogeneity.
“It is imperative that anxiety and depression be considered alongside pain and disability when assessing younger people with chronic pain and, if relevant, that younger people be provided access to timely psychological care to improve pain outcomes alongside mental health,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Better Youth Fitness May Lower Risk for Depression in Adulthood
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Withdrawal From Medetomidine Increasingly Seen in ICUs
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl